Federal Trade Commission, "COVID-19 Consumer Protection Act of the 2021 Consolidated Appropriations Act"

Summary

The FTC's page on the COVID-19 Consumer Protection Act, part of the 2021 Consolidated Appropriations Act (Pub. L. No. 116-260), says the Act makes deceptive practices tied to COVID-19 treatment, cure, prevention or diagnosis, or to a COVID-19 government benefit, unlawful under Section 5 of the FTC Act. It applies for the duration of the public health emergency and treats a violation as a violation of an FTC rule.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

COVID-19 Consumer Protection Act of the 2021 Consolidated Appropriations Act

Tags:

Mission

Consumer Protection

Law

Pub. L. No. 116-260, 134 Stat. 1182, Division FF, Title XIV, § 1401

Links

https://www.ftc.govhttps://www.congress.gov/116/bills/hr133/BILLS-116hr133enr.pdf

For the duration of the COVID-19 public health emergency declared pursuant to section 319 of the Public Health Service Act (42 U.S.C. 247d), this Act makes it unlawful under Section 5 of the Federal Trade Commission Act for any person, partnership, or corporation to engage in a deceptive act or practice in or affecting commerce associated with the treatment, cure, prevention, mitigation, or diagnosis of COVID–19 or a government benefit related to COVID–19. The Act provides that such a violation shall be treated as a violation of a rule defining an unfair or deceptive act or practice prescribed under Sec. 18(a)(1)(B) of the FTC Act.

File and source

File

ftc-statute-covid-19-consumer-protection-act.html

Size

986,095 bytes

SHA-256

7bad21898c390ae4b4b5b18ef162111ae2c74417f5ee82fdeb909c1e5158e034

Our copy

ftc-statute-covid-19-consumer-protection-act.html

Original

www.ftc.gov